Literature DB >> 11077047

Serine and alanine mutagenesis of the nine native cysteine residues of the human A(1) adenosine receptor.

D J Scholl1, J N Wells.   

Abstract

To examine the importance of the nine native cysteine residues in the human A(1) adenosine receptor, each cysteine was individually mutated to both serine and alanine. Saturation binding with the A(1) selective antagonist [(3)H]DPCPX [8-cyclopentyl-1,3-di(2, 3-(3)H-propyl)xanthine] resulted in a wild-type K(d) value of 0.92 nM. All serine and alanine mutants had similar K(d) values with the exception of serine/alanine mutations at Cys80 and Cys169. These two cysteine residues, which are highly conserved in G protein-coupled receptors and hypothesized to be linked through a disulfide bridge, demonstrated no detectable binding with [(3)H]DPCPX. Both serine and alanine mutations at residues Cys80 and Cys169 resulted in receptors that were not detectable at the cell surface, as visualized by immunostaining. The serine/alanine mutants that did bind [(3)H]DPCPX were characterized further through competition binding with the antagonist theophylline and the agonists NECA (5'-N-ethylcarboxamidoadenosine) and R-PIA [(R)N(6)-phenylisopropyl adenosine]. The wild-type theophylline K(i) value was 2.41 microM, with the serine/alanine mutants having similar values. Wild-type NECA and R-PIA K(i) values were 0.74 microM and 97.0 nM, respectively. All mutants had K(i) values similar to wild-type with the exception of the Cys85Ser mutant, which had NECA and R-PIA values of 9.30 microM and 387.3 nM, respectively. These data show that Cys80 and Cys169 are absolutely required for delivery of the receptor to the plasma membrane. The Cys85Ser data indicate that although a cysteine is not required at this position, this residue may have an important role in ligand binding or for the structure of the receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11077047     DOI: 10.1016/s0006-2952(00)00474-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

1.  The rat adenine receptor: pharmacological characterization and mutagenesis studies to investigate its putative ligand binding site.

Authors:  Melanie Knospe; Christa E Müller; Patrizia Rosa; Aliaa Abdelrahman; Ivar von Kügelgen; Dominik Thimm; Anke C Schiedel
Journal:  Purinergic Signal       Date:  2013-02-15       Impact factor: 3.765

2.  Role of extracellular cysteine residues in the adenosine A2A receptor.

Authors:  Elisabetta De Filippo; Vigneshwaran Namasivayam; Lukas Zappe; Ali El-Tayeb; Anke C Schiedel; Christa E Müller
Journal:  Purinergic Signal       Date:  2016-03-11       Impact factor: 3.765

3.  Conserved disulfide bond is not essential for the adenosine A2A receptor: Extracellular cysteines influence receptor distribution within the cell and ligand-binding recognition.

Authors:  Andrea N Naranjo; Amy Chevalier; Gregory D Cousins; Esther Ayettey; Emily C McCusker; Carola Wenk; Anne S Robinson
Journal:  Biochim Biophys Acta       Date:  2014-11-16

4.  Neurabin scaffolding of adenosine receptor and RGS4 regulates anti-seizure effect of endogenous adenosine.

Authors:  Yunjia Chen; Yin Liu; Christopher Cottingham; Lori McMahon; Kai Jiao; Paul Greengard; Qin Wang
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

5.  The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.

Authors:  Veli-Pekka Jaakola; Mark T Griffith; Michael A Hanson; Vadim Cherezov; Ellen Y T Chien; J Robert Lane; Adriaan P Ijzerman; Raymond C Stevens
Journal:  Science       Date:  2008-10-02       Impact factor: 47.728

Review 6.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors.

Authors:  B B Fredholm; A P IJzerman; K A Jacobson; K N Klotz; J Linden
Journal:  Pharmacol Rev       Date:  2001-12       Impact factor: 18.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.